Reduced-intensity conditioning allogeneic stem cell transplantation with donor T-cell depletion using alemtuzumab added to the graft ('Campath in the bag').

MLA

von dem Borne, Peter A., et al. “Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation with Donor T-Cell Depletion Using Alemtuzumab Added to the Graft ('Campath in the Bag’).” Current Opinion in Oncology, vol. 21 Suppl 1, June 2009, pp. S27–29. EBSCOhost, https://doi.org/10.1097/01.cco.0000357472.76337.0e.

APA

von dem Borne, P. A., Starrenburg, C. W. J. I., Halkes, S. J. M., Marijt, W. A. E., Fibbe, W. E., Falkenburg, J. H. F., & Willemze, R. (2009). Reduced-intensity conditioning allogeneic stem cell transplantation with donor T-cell depletion using alemtuzumab added to the graft ('Campath in the bag’). Current Opinion in Oncology, 21 Suppl 1, S27–S29. https://doi.org/10.1097/01.cco.0000357472.76337.0e

Chicago

von dem Borne, Peter A, C W J Ingrid Starrenburg, Stijn J M Halkes, W A Erik Marijt, Willem E Fibbe, J H Frederik Falkenburg, and Roel Willemze. 2009. “Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation with Donor T-Cell Depletion Using Alemtuzumab Added to the Graft ('Campath in the Bag’).” Current Opinion in Oncology 21 Suppl 1 (June): S27–29. doi:10.1097/01.cco.0000357472.76337.0e.